One surgery for pancreatic cancer and liver spread: safe or risky?
NCT ID NCT07446946
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at hospital records from Germany over 14 years to see how often surgeons remove both the pancreatic tumor and any liver metastases in a single operation. The goal was to understand current practice and check whether adding liver surgery increases the risk of death shortly after the procedure. The study focused only on short-term safety during the hospital stay, not on long-term survival or cure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- surgery (simultaneous removal of pancreatic tumor and liver metastases)
- What this could lead to
- If this study shows that combined surgery is safe, it could support offering this option to more carefully selected patients with pancreatic cancer that has spread to the liver.
- What could go wrong
- This is an observational study using past hospital records, not a controlled trial. It only looks at short-term safety, not long-term survival or cure. The results may not apply to all patients or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER WITH LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.